In addition, this is increasingly important in light of the identification of smoking as a key risk factor for non-response to anti-TNF agents in patients with CD.[14] However, the global prevalence of smoking associated with IBD have not been collated and reported. The gene discussed is TNF; the disease is inflammatory bowel disease.